2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow RSV Infection: new trials by email Literature Review of RSV Infection trials Research Report on RSV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose RSVpreF, Placebo - RSV Infection | Phase 3 | Recruiting | Pfizer | 550 | 2025-04-16 | 2026-10-14 |
| Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) Clesrovimab, Palivizumab, Placebo - RSV Infection | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1003 | 2021-11-30 | 2026-05-08 |
| Effect of Heliox on RSV Bronchiolitis Heliox, Air - RSV Infection, Acute Bronchiolitis | Phase 3 | Completed | Wael Seliem | 104 | 2015-05-01 | 2017-05-31 |
Respiratory Syncytial Virus Infections (3)
Infections (3) · Mononegavirales Infections (3) · Paramyxoviridae Infections (3) · Pneumovirus Infections (3) · RNA Virus Infections (3) · Virus Diseases (3)
Air (1) · MK-1654 (1) · Palivizumab (1) · heliox (1)
Merck Sharp & Dohme LLC (1) · Pfizer (1) · Wael Seliem (1)
South Africa (2) · United States (2) · Argentina (1) · Australia (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Hungary (1) · Italy (1)